Literature DB >> 3076454

Aberrant expression during two-stage mouse skin carcinogenesis of a type I 47-kDa keratin, K13, normally associated with terminal differentiation of internal stratified epithelia.

R Nischt1, D R Roop, T Mehrel, S H Yuspa, M Rentrop, H Winter, J Schweizer.   

Abstract

Specific keratin cDNA probes and monospecific antikeratin antisera were used to analyze mouse epidermis and epidermal tumors for the expression of a type I 47-kDa keratin, K13, normally associated with terminal differentiation of internal stratified epithelia. We demonstrated that this keratin was virtually absent from the entire body epidermis at various stages of development. Also, it was not detected in various forms of acute and chronic epidermal hyperproliferation or in epidermal cells cultured under conditions that favored either cell proliferation or in vitro differentiation. In contrast, K13 was consistently expressed in squamous cell carcinomas of the skin induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate (TPA), whereas papillomas obtained by the same two-stage protocol were distinctly heterogeneous with regard to the expression of this keratin. These findings were true for two different strains of mice (NMRI and Sencar). Papillomas collected from Sencar mice after 12 wk or from NMRI mice after 15 wk of promotion with TPA were either negative for K13 or elicited variable amounts of this keratin. In all cases of positive expression of K13 in tumors, as in normal stratified internal epithelia, both the keratin protein and its mRNA invariably occurred in the differentiating cell compartments. In contrast to what we found in internal stratified epithelia, however, K13 was expressed without its commonly encountered type II 57-kDa partner, K4. Papillomas negative for the K13 protein were also devoid of K13 transcripts. This indicates that the aberrant K13 expression in tumors is regulated at the level of transcription. Our results suggest that K13 may provide a marker for malignant conversion in the mouse two-stage skin carcinogenesis model and may be especially suited for studies of gene expression regulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3076454     DOI: 10.1002/mc.2940010205

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  22 in total

1.  Mutated c-Ha-ras oncogene alters cytokeratin expression in the human breast epithelial cell line MCF-10A.

Authors:  T M Paine; G Fontanini; F Basolo; I Geronimo; J W Elliott; J Russo
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

2.  TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma.

Authors:  Naoki Oshimori; Daniel Oristian; Elaine Fuchs
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

Review 3.  Oncogenic regulation and function of keratins 8 and 18.

Authors:  R G Oshima; H Baribault; C Caulín
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

4.  Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases.

Authors:  H E Schaafsma; F C Ramaekers; G N van Muijen; H Robben; E B Lane; I M Leigh; E C Ooms; J A Schalken; R J van Moorselaar; D J Ruiter
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

5.  Loss of Desmocollin 3 in skin tumor development and progression.

Authors:  Jiangli Chen; Charlene O'Shea; James E Fitzpatrick; Maranke I Koster; Peter J Koch
Journal:  Mol Carcinog       Date:  2011-06-16       Impact factor: 4.784

6.  Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.

Authors:  A B Glick; A B Kulkarni; T Tennenbaum; H Hennings; K C Flanders; M O'Reilly; M B Sporn; S Karlsson; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Expression of the carcinoma-associated keratin K6 and the role of AP-1 proto-oncoproteins.

Authors:  F Bernerd; T Magnaldo; I M Freedberg; M Blumenberg
Journal:  Gene Expr       Date:  1993

Review 8.  Transgenic mice and squamous multistage skin carcinogenesis.

Authors:  K Brown; A Balmain
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

9.  Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications.

Authors:  Erika L Abel; Joe M Angel; Kaoru Kiguchi; John DiGiovanni
Journal:  Nat Protoc       Date:  2009-08-27       Impact factor: 13.491

10.  Overlapping loss of heterozygosity by mitotic recombination on mouse chromosome 7F1-ter in skin carcinogenesis.

Authors:  A B Bianchi; N M Navone; C M Aldaz; C J Conti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.